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The small DNA genomes of papillomaviruses contain a surprisingly large number of regulatory or
cis-responsive elements, which regulate replication and transcription of the virus, and control details like
speciﬁcity for certain epithelial cells, speciﬁcity for layers in squamous epithelia, feedback mechanisms
and coupling between host cell physiology and virus biology. Most of these elements occur in the long
control region, while others are located elsewhere in the genome. Many papillomaviruses show a similar
composition of cis-responsive elements, although these are scattered and do not occur as long segments
of sequence similarity. This review summarizes our knowledge of the regulatory elements in several
well-studied Alphapapillomavirus types, and indicates some similarities to other papillomavirus genera,
whose properties are yet poorly understood.
& 2013 Elsevier Inc. All rights reserved.Introduction
Regulatory or cis-responsive elements modulate the transcrip-
tion of all genes including, of course, those of papillomaviruses.
They are of eminent importance for the viral biology, as they
determine the range of epithelial cell types the virus can infect,
couple the expression of early and late genes to the differentiation
of squamous epithelia, modulate virus biology in response to
hormones and growth factors, affect the amount of viral gene
expression by feedback control and integrate viral gene expression
and replication.
Regulatory elements are short DNA sequence motifs that are
recognized and bound by regulatory proteins, namely transcrip-
tional activators, repressors, terminators and initiators of replica-
tion. From a position bound to their speciﬁc target sequence,
regulatory proteins affect the general transcription factors of the
pre-initiation complex, RNA polymerase II and its cofactors,
histones and DNA polymerases and thereby modulate the rate of
transcription initiation and elongation and replication initiation.
Maps of the regulatory elements in papillomavirus genomes are
therefore useful to predict regulatory pathways that likely affect
the viral biology.
Regulatory elements can often be detected by mere sequence
analysis, but conﬁrmation of binding of speciﬁc factors requires
experimental evidence such as gelshifts (bandshifts), supershifts
with antibodies and footprint experiments, and functional assays,
for example with chimeric reporter genes that are assayed in
transfection experiments.ll rights reserved.The study of the regulatory elements of papillomaviruses
progressed rapidly for about 15 years beginning with the late-
1980s, but attracted comparably low research activity in the last
decade, although the understanding of fundamental regulatory
phenomena such as epithelial-speciﬁcity and the early-late switch
is still far from mature. Most research was directed at the
medically important papillomavirus types HPV6, 11, 16, 18 and
31, and these results are the principal focus of this chapter.
Transcriptional studies of HPV8, BPV1 and BPV4 are just men-
tioned, when they point to major mechanistic differences between
papillomaviruses of different genera. As far as it is known today,
regulation of transcription of HPV6, 11, 16 and 18 shows many
similarities and many mechanisms likely exist similarly in most
unstudied Alphapapillomaviruses, but deviate in many important
ways from those used by papillomaviruses from other genera.Overlapping content of this chapter with other articles in this
issue
Papillomavirus genomes themselves encode a transcription factor,
E2, which affects gene activation and repression and yet other
biological functions by binding to the sequence ACCGNNNNCGGT,
which has multiple copies in every papillomavirus genome. As
papillomavirus E2 research has developed into an extensive specialty,
we have assigned it to a separate chapter (McBride, this issue), and to
avoid duplication, E2 related phenomena are only marginally men-
tioned in this chapter on regulatory elements. Papillomavirus tran-
scription is also affected by DNA methylation at E2 sites and at any
other CpG dinucleotide of the genome, thereby creating sequence
unspeciﬁc binding sites for a family of transcriptional repressors
speciﬁc for methylated CpGs. The study of this phenomenon, which
Fig. 1. General overview of the organization of the long control region of all alphapapillomaviruses.
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rapidly expanded, as it may have signiﬁcant impact on clinical
diagnosis. As a separate chapter addresses methylation of papillo-
mavirus DNA (Lambert, this issue), its impact on papillomavirus
transcription is not discussed in this article.Topology of the LCR of Alphapapillomaviruses
The LCR, which does not contain any open reading frames,
encompasses roughly 10% of the genome of most papilloma-
viruses, precisely 850 bp of the 7906 bp genome of HPV16. It is
typically illustrated with the left end bordering at the termination
codon of the L1 gene (5′ part of LCR) and the transcription start of
the E6 gene on the right side (3′ part of LCR) (Fig.1). The 3′ part of
the LCR contains the major transcription start site (P97 in HPV16,
P105 in HPV18) of the E6 promoter, the only strong and highly
reproducible promoter in the LCR. The LCRs of all Alphapapilloma-
viruses have similar overall topologies marked by four ACCGN-
NNNCGGT binding sites of the viral E2 protein (Fig. 1). Two of
these sites (E2BS1 and 2) are about 50 bp upstream of the
transcription start site, a third site (E2BS3) is about another
100 bp further upstream, and a fourth site (E2BS4) about halfway
between the end of L1 and E2BS3. The segment between E2BS4
and E2BS3 can be called “central LCR”, and the other two segments
the 5′ and 3′ parts of the LCR. None of these segments has long
stretches of sequence similarity when different Alphapapilloma-
virus types are aligned, but they share short sequence motifs that
identify similar regulatory elements. The 5′ part of the LCR encodes
the transcription termination signal of the late transcripts, the
central LCR enhancer and silencer elements, and the 3′ part of the
LCR the replication origin and the E6 promoter, as discussed in
detail in the following paragraphs. In spite of extensive sequence
diversity between the LCRs of remotely related human Alphapa-
pillomavirus types and between them and Alphapapillomavirus
types from Macaca monkeys (Chen et al., 2009), this overall
topology as well as most speciﬁc regulatory elements (see below)
have remained conserved over several ten million years, suggest-
ing an indispensible function of speciﬁc sequence arrangements
and regulatory elements for Alphapapillomavirus biology.
The 3′ part of the LCR and the E6 promoter
The E6 promoters of HPV11, HPV16 and HPV18 and all known
alphapapillomaviruses have a characteristic arrangement of four
sequence elements. Like in many promoters used by RNA poly-
merase II, the transcription start site is preceded by a TATA box
(TATAAA, 31 to 26 bp upstream of the transcription start site),which serves to bind the pre-initiation complex composed of TFIID
with the TATA box binding subunit TBP, other general transcription
factors and the RNA polymerase II. Another 37-32 bp upstream of
the TATA box is a G rich hexamer, GGGCGT in the case of HPV16,
which is an SP1 binding site (Gloss and Bernard, 1990). SP1 is an
activating transcription factor, initially identiﬁed binding the
“21 bp repeats” of the SV40 early promoter. This regulatory
element is necessary for E6 promoter activity, which contributes
to the preferential transcriptional activity of HPVs in epithelial
cells. SP1 is a member of a family of homologous transcription
factors and is available as an activator in epithelial cells, while its
relative SP3, binding the same target, functions as a repressor of
the E6 promoter in ﬁbroblasts (Apt et al., 1996).
Two of the four E2 binding sites of Alphapapillomaviruses, E2BS1
and 2, are positioned exactly between the SP1 binding site and the
TATA box. Their principal function appears to be to interfere with the
binding of SP1 and TFIID and thereby with E6 promoter function, an
observation conﬁrmed for HPV11, 16 and 18 (Dostatni et al., 1991; Tan
et al., 1992, 1994; Demeret et al., 1994, 1997; Dong et al., 1994; Zhao
et al., 1997). This is clearly a negative feedback loop that evolved to
keep the E6 promoter at a low steady-state activity, as increased E6
promoter activity raises also the level of E2 transcripts and conse-
quently of E2 proteins. It has remained somewhat enigmatic, why the
E2 protein of Alphapapillomaviruses functions as an excellent tran-
scriptional activator when it targets E2 dependent enhancers like
that of BPV1, mimicking the function of the homologous protein of
BPV1, since no such enhancer is known in Alphapapillomaviruses. A
minor activation function of the Alphapapillomavirus E2 protein was
detected in experimental conditions of low E2 protein expression,
possibly when E2 displaces SP1 bound to its distal target site E2BS2
and thereby occupies an “activator position”, while full repression
may rather come about by competition between TFIID and SP1
bound to the proximal site E2BS1. Strangely, however, one paper
reported that this transcriptional stimulation did not require the
domain of E2 required for transactivation (Demeret et al., 1994).
SP1 and E2 binding sites and the TATA box are the principal
conserved regulatory motifs upstream of the E6 promoter of
Alphapapillomaviruses, and there are no conserved CCAAT boxes,
which are relevant regulatory elements of many cellular genes.
Nevertheless, there are multiple reports of modulation of alpha-
papillomavirus E6 promoters by CCAAT-enhancer-binding proteins
(C/EBPs), which bind CCAAT boxes of promoters of some cellular
genes. These publications will be discussed below in the context of
C/EBP effects on other parts of the LCR.
Yet other factors maymodulate HPV16 P97, such as YY1 (see details
and functions in the context of the enhancer/silencer below), as Lace
et al. (2009) reported binding of YY1 to two sites overlapping with and
downstream of P97, respectively, reducing transcriptional activity.
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The replication of papillomaviruses depends on the viral E1 and
E2 proteins, and is discussed in detail in two separate chapters in
this issue. In the context of “regulatory elements” it should just be
mentioned that E1 binding sites are AT rich nucleotide stretches
with lengths of about 20 bp without precise sequence conserva-
tion (Russell and Botchan, 1995). A frequent motif, TAAT, is
modiﬁed in some papillomaviruses to the sequence CAAT, and
this sequence is sometimes erroneously interpreted as a CCAAT
box, the common element of eukaryotic promoters. While E1
executes interactions with cellular proteins relevant for replication
initiation, it has low binding speciﬁcity to its target sequence. This
is compensated by the formation of a complex between E1 and E2,
and this complex makes use of the precise sequence recognition of
E2 to adjacent E2 binding sites. Alternative E2 binding sites around
any particular E1 binding site can complement each other's
function, notably E2BS1, 2 and 3 of Alphapapillomaviruses, and
together stimulate replication synergistically (Mohr et al., 1990;
Remm et al., 1992; Russell and Botchan, 1995).
The central LCR and enhancer and silencer functions
When various alternative segments of the central LCR of HPV16
and HPV18 were cloned into vectors with reporter genes under
control of homologous (i.e. HPV derived) or heterologous promoters
and transfected into cell cultures, strong (up to several hundred fold)
transcriptional activation could be detected. These experiments
identiﬁed the location of a transcriptional enhancer, i.e. a piece of
DNA with numerous regulatory elements that “hyperactivate” tran-
scription. The activity is cell type dependent, and strong in many
types of epithelial cells, for example, in HeLa cells, but weak in
ﬁbroblasts (Cripe et al., 1987; Gloss et al., 1987; Swift et al., 1987;
Lung et al., 2011; Weyn et al., 2011). This property has been called an
“epithelial-speciﬁc” or “keratinocyte-dependent” enhancer. While
widely used, the latter term is somewhat unfortunate, as the term
keratinocytes identiﬁes normally skin cells and does not include
squamous mucosal cells, the normal HPV16 and 18 targets.
It was overlooked for a number of years that examination of the
contiguous central LCR and 3′ part of the LCR (as opposed to
chimeric constructs representing only part of these segments), a
much lower transcriptional activity is detected (Sailaja et al., 1999;
Ottinger et al., 2009). This enigma is explained by the existence of
a “silencer” between the enhancer and E6 promoter (Bauknecht
et al., 1992, 1995; O'Connor et al., 1996, 1998, 2000; Ai et al., 1999),
i.e. a cluster of regulatory elements that repress the activating
function of the enhancer. In summary, the central and the 3′ part
of the LCR are composed of numerous cis-responsive elements,
which are affected individually, but which modulate synergisti-
cally or antagonistically E6 promoter activity over a range of two to
three orders of magnitude. The following paragraphs will describe
efforts to dissect these functions associated with the central LCR.
The central LCR and NFI sites
The most conspicuous sequence element of the central LCR of
Alphapapillomaviruses (and also of some papillomaviruses from other
genera) is a cluster of TTGGC motifs, which can occur on the upper
and lower DNA strands. For example, HPV6 has ﬁve, HPV16 seven
and HPV18 four TTGGC motifs. As the probability for such clusters to
occur by chance is close to zero, one has to conclude that these sites
serve a unique function in papillomavirus biology. Footprint and
bandshift experiments (Gloss et al., 1989a, 1989b) conﬁrmed that
these sequence motifs are binding sites for the transcription factor
NFI/CTF. This factor normally binds the palindrome TTGGCAN3TGC-
CAA as originally detected in the adenovirus replication origin (Pjanicet al., 2011). It has never been understood, why there are only the
lower-afﬁnity half-palindromic sites in papillomaviruses.
NFI constitutes a family of factors derived from four genes,
NFI-A, B, C and X. NFI factors occur in dimeric form, with the two
subunits potentially derived from the four different NFI genes and
also from different spliced products. The permutation of all these
different subunits allows generating a large number of homo- and
heterodimers, and the exact functional properties of all these
alternatives have never become well understood. NFI is known to
be a transcriptional activator (Gronostajski, 2000; Pjanic et al.,
2011), and mutational analyses have shown that NFI binding sites
activate HPV enhancers in synergy with other factors (Gloss et al.,
1989a, 1989b; Chong et al., 1990, 1991; Sen et al., 2004; Baldwin
et al., 2007), although some studies could only detect weak effects
(Butz and Hoppe-Seyler, 1993; Parker et al., 1997). NFI sites appear
to contribute to the epithelial speciﬁcity of HPV enhancers, as
overexpression of the NFI-X gene, the NFI factor that dominates in
ﬁbroblasts, represses HPV enhancer activity in natural epithelial
host cells of HPVs (Apt et al., 1993, 1994).
NFI appears to play an important role in the modulation of HPV16
transcription during carcinogenesis, as it was observed that the
transforming growth factor beta (TGF-beta) reduces NFI activity
mediated via a decrease in the activity of the synergizing factor Ski
(Baldwin et al., 2004, 2007), a tumor suppressive mechanism that is
lost during the development of malignant disease.
The central LCR and AP1 sites
AP1 is one of the best-studied transcription factors, as it is an
important target downstream of tyrosine kinase signaling cascades.
AP1 is a heterodimer composed of subunits of the fos and jun gene
family. The typical AP1 dependent regulatory element is the
sequence TGANTCA, but major modiﬁcations of this motif can also
be bound. It is therefore not as easy as in the case of NFI to predict
binding sites by sequence inspection alone, and AP1 sites need to be
conﬁrmed by bandshift, supershift and footprint experiments. AP1
sites have been experimentally conﬁrmed in HPV11, 16, 18 and 31
(Garcia-Carranca et al., 1988; Chan et al., 1990; Chong et al., 1990,
1991; Thierry et al., 1992; Butz and Hoppe-Seyler, 1993; Dollard et al.,
1993; Medina-Martinez et al., 1996; Kyo et al., 1997; Parker et al.,
1997; Sen et al., 2004) and several of these publications suggest that
AP1 makes the quantitatively most signiﬁcant contribution to HPV
enhancer activities and may be the “principal activator” of the
enhancers. Beyond these experimental ﬁndings, sequence inspection
suggests that AP1 sites occur in many Alphapapillomaviruses,
although no good matches to the TGANTCA motif can be found in
some types such as HPV2, 27 and 57, which are related and cause
common skin warts.
The subunit composition of AP1 factors differs in different cell
types and apparently also in different layers of squamous epithelia,
making AP1 another likely contributor to the epithelial preference of
papillomavirus transcription and a modulator during epithelial
differentiation (Thierry et al., 1992; Welter and Eckert, 1995). As
expected, papillomavirus transcription can be stimulated in cell
culture by phorbolesters (Chan et al., 1990), which simulate the
effects of signaling cascades, and it is therefore likely that papillo-
mavirus transcription increases in situ in response to ligands such as
the epidermal growth factor.
The central LCR and Oct1 sites
Oct1 is a member of the POU factors, and all members of this
transcription factor family bind the consensus recognition sequence
ATGCAAAT. However, from the study of regulatory elements other
than those found in papillomaviruses, it is well established that Oct1
and other POU factors also bind motifs very divergent from the
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sequence inspection is not an exhaustive tool to predict POU factor
binding sites. Beyond this, experimentally conﬁrmed Oct1 binding
sites of papillomaviruses could be modulated in situ by POU factors
other than Oct1. Candidates are the epithelial speciﬁc POU factors Skn-
1a/I and Tst-1/Oct-6 (Andersen et al., 1997), but potential effects of
such factors on Alphapapillomaviruses have never been studied.
Perfectly conserved Oct1 motifs exist in the LCR of all Alphapa-
pillomavirus-7 and 9 types exactly spaced by 2 bp from a half-
palindromic NFI site, i.e. the sequence AATTGCATnnTTGGC, and lead
with HeLa nuclear extracts to complexes with identical bandshift
behavior as a bona ﬁde Oct1 motif (O'Connor and Bernard, 1995). The
combination of the two sites leads to transcriptional stimulation of a
linked promoter, possibly through a mechanism where Oct1 tethers
NFI to the enhancer rather than being a transcriptional activator by
itself.
The central LCR and TEF1 sites
Just like AP1 and Oct1, TEF-1 is yet another factor originally
detected in the dissection of the SV40 enhancer. A detailed study,
involving supershift experiments, suggested that it binds multiple
sites in the HPV16 enhancer including the motifs ACATACCG and
ACATATTT, and mutations of these motifs abrogate enhancer
activity. This factor and its transcriptional cofactors occur prefer-
entially in certain keratinocytes, and may contribute to the
epithelial speciﬁc function (Ishiji et al., 1992). While the same
researchers detected contributions of TEF-1 to a cell-type unspe-
ciﬁc enhancer of BPV1 (Haugen et al., 2009), the factor has not yet
been studied in the context of the enhancer of other Alphapapillo-
maviruses but HPV16.Action of C/EBPalpha and C/EBPbeta on the central and 3′ part
of the LCR
The early transcription literature of the 1980s outside the HPV
ﬁeld observed that many cellular promoters contain “CCAAT
boxes” 50–60 bp upstream of the transcription start site, leading
to the assumption that a unique factor may activate these
promoters. Extensive and complex research has subsequently
shown that CCAAT boxes and related sequences are bound by
three different factors, NFI/CTF, NFY and C/EBP. Each of these
alternative factors is very complex in its own right, being derived
from members of multigene families, and whose products are
able to form homo- and heterodimers (Gronostajski, 2000). The
relevance of NFI/CTF for HPVs has been discussed above. NFY has
not been implicated in the transcription of papillomaviruses. The
following is a brief summary of reports of an impact of the third
factor, the members of the C/EBP family on HPV promoters and
enhancers.
C/EBPs are a family of seven transcription factors that bind
varieties of the consensus sequence ATTGCGCAAT, and some of
these are expressed in epithelial cells (Maytin and Habener, 1998),
and three, C/EBPalpha, beta and delta, have effects on HPVs. NF-
IL6/C/EBPdelta and C/EBPbeta were proposed to be negative
regulators of HPV16 and HPV11, but the binding sites were not
unequivocally documented (Kyo et al., 1993; Wang et al., 1996).
Ralph et al. (2006) reported alternation between activating and
repressing function of C/EBP bound to a site at position 7774
depending on occupancy of an adjacent YY1 site. Out of three
isoforms of C/EBPbeta, two were observed to activate and one to
repress HPV16 transcription (Struyk et al., 2000). A C/EBP site in
the silencer of HPV18 synergizes with YY1 and represses the LCR
in HeLa cells, while this constellation activates in HepG2 cells
(which are not natural hosts of HPVs) (Bauknecht et al., 1996;Bauknecht and Shi, 1998). An increase in C/EBPbeta binding to the
LCR of HPV31 has been attributed to histone modiﬁcations that
favor a transcriptionally active state in response to epithelial
differentiation (Wooldridge and Laimins, 2008). Mutation of a C/
EBP binding site in HPV11 led to upregulation of the viral
enhancer, suggesting a repressing function of this transcription
factor family (Zhao et al., 1997).
Outside of the LCR, C/EBPalpha bound at position 460 down-
stream of the P97 promoter of HPV16 has been proposed to
synergize with CBP and E2 protein, a rare example of transcrip-
tional activation by E2 in HPVs (Krüppel et al., 2008). C/EBPalpha
and beta form complexes with E2, which could lead to transcrip-
tional effects by the former factor via E2 binding sites (Hadaschik
et al., 2003).Regulation by steroid hormones
Although the stress-hormone glucocorticoid and the
pregnancy-hormone progesterone have physiologically very dis-
tinct functions, their receptors act through similar or even iden-
tical regulatory elements, namely sequences similar to the
palindrome AGAACANNNTGTTCT. Three such regulatory elements
have been found in the LCR of HPV16, which is stimulated by both
hormones (Gloss et al., 1987; Chan et al., 1989; Mittal et al., 1993).
Related sequences were detected in HPV11 and HPV18 (Chan et al.,
1989), although only the element of the latter virus mediated
hormonal stimulation when tested in the context of the whole LCR
(Medina-Martinez et al., 1996; Zhao et al., 1997; Bromberg-White
and Meyers, 2002, 2003). HPV31 does not respond to these two
steroid hormones (Bromberg-White and Meyers, 2002). Estrogen
mediates its effects through a similar but slightly different
sequence element, which does not seem to occur in Alphapapillo-
maviruses, although a preliminary report of estrogen regulation
should be noted (Mitrani-Rosenbaum et al., 1989). It is likely that
the well established epidemiological ﬁndings that multiparity and
longtime use of contraceptives have a molecular foundation in the
increased expression of the HPV oncoproteins by glucocorticoids
and progesterone (Pater et al., 1988), while suspected pathogenic
effects of estrogen in cervical carcinogenesis may rather be
mediated by effects of the hormone on the viral host cell (Chung
et al., 2010).The central LCR and factors of unconﬁrmed identity
On the way to analyze transcription factor binding sites and the
bound transacting factors, (degenerated) consensus sequences can
only serve as the foundations for hypotheses and guidelines to
search for these factors. Occupancy has to be conﬁrmed by band-
shift and/or footprint experiments. The factor's true identity can, in
theory, only be determined by puriﬁcation and protein sequen-
cing, although supershifts with speciﬁc antibodies are an extre-
mely strong identiﬁcation tool. The search for regulatory elements
of HPV LCRs repeatedly led to observations, where only a subset of
these conditions was fulﬁlled. For example, bandshift data some-
times suggest occupancy of a sequence not reminiscent of known
binding sites, and functional contributions of an unrecognized
factor. Examples are PVF, or papillomavirus factor, proposed by our
own group, which may be identical with TEF-2 that activates SV40
(Chong et al., 1990), the papillomavirus enhancer binding factor-1
(Cuthill et al., 1993), and the keratinocyte speciﬁc transcription
factor (Mack and Laimins, 1991). While data support existence and
a functional role of such factors, their true identity needs to be
revisited.
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YY1 is a multifunctional transcription factor that exhibits
complex positive and negative controls. It binds the consensus
sequence CCGCCATNTT and numerous degenerate motifs. It can
activate or repress transcription directly, e.g. by interacting with
histone-deacetylases or histone-acetyltransferase, or indirectly by
interacting with other transcription factors. There are numerous
suspected or conﬁrmed YY1 binding sites throughout the LCR of
HPVs. Several of these are clustered between the enhancer in the
central LCR and the E6 promoter of HPV6, HPV16 and HPV18
(Bauknecht et al., 1992, 1995, 1996; O'Connor et al., 1996; Ai et al.,
2000). The YY1 sites in this position function as negative regula-
tory elements or silencers (Bauknecht et al., 1992; O'Connor et al.,
1996). YY1 sites may be one of the reasons that the contiguous
HPV LCR shows only moderate transcriptional activity (Ottinger
et al., 2009) (as opposed to chimeric test vectors that examine only
part of the central LCR), i.e. YY1 may reduce the transcriptional
stimulation by activators such as AP-1, NFI, Oct1 and TEF-1.
Interaction of YY1 with C/EBPbeta bound to an adjacent motif
has been proposed to constitute a switch between activation and
repression of the HPV enhancer (Bauknecht et al., 1995, 1996).
The central LCR and silencing by CDP
CCAAT-displacement protein (CDP) is a well studied transcrip-
tional repressor, which functions through an associated histone
deacetylase activity. CDP binds several motifs throughout the
HPV6 LCR in the 5′, central, and 3′ LCR (Pattison et al., 1997;
Ai et al., 1999). HPV16 contains, overlapping with its E1 binding
site, the sequences TATAATAAT and TACAATAAT, which also bind
CDP, silence the HPV enhancer (O'Connor et al., 1998, 2000) and
interfere with the function of E1 (Narahari et al., 2006). Similar
CDP binding motifs occur in the same position of many other and
possibly all papillomaviruses and have been shown to bind CDP in
HPV2, 11, 18, 31, 33 and 45 (O'Connor et al., 2000), suggesting that
negative modulation of transcription and replication by CDP may
be a general mechanism central to the papillomavirus life cycle, as
CDP expression (decreasing in differentiating epithelial cells) and
E6/E7 expression (increasing in differentiating epithelial cells) are
inversely correlated (Ai et al., 1999).
The 5′ LCR and E2BS4
As the LCRs of different Alphapapillomaviruses are very divergent, it
is reasonable to assume that conservation of the overall architecture
and of individual sequence motifs must have eminent relevance for
the overall lifecycle of the virus. Against this logic, there is a dearth of
information why the length and some sequences in 5′ LCR segment,
which makes up about 35% of the whole LCR of Alphapapillomavirus,
are conserved. The 5′ LCR contains a singular motif of eminent
importance, namely a termination site for transcription of the late
genes L2 and L1, AATAAA, about 100 bp downstream of the translation
termination codon of L1. In tests of the 5′ LCR of HPV31, this segment
functions as an auxiliary enhancer (Kanaya et al., 1997; Hubert et al.,
1999), a function that has not been conﬁrmed for other Alphapapillo-
maviruses, and which seems somewhat redundant in view of the
strong effects of the principal enhancer of the central LCR. Most
confusing is the strict conservation of E2BS4, which conceptually
separates the 5′ and the central LCR, which does not have any known
function in spite of its presence in all Alphapapillomaviruses. Our group
has characterized a YY1 dependent transcriptional initiator and start
site 18 bp upstream of E2BS4 that is conserved among different
Alphapapillomaviruses (Tan et al., 2003), but could not reveal a
biological function in vivo of this potential YY1-E2 synergy in spite
of strong activities in vitro.High-throughput scanning for additional transcription factors
affecting the HPV16 and HPV18 LCR activity
Until recently, most dissections of transcription factor binding
sites in HPV LCRs were founded on sequence inspection and
conﬁrmed by bandshift analysis. In contrast, a recent powerful
approach searched for functional effects of 704 different transcrip-
tion factors on the HPV16 and HPV18 LCR activity in a high-
throughput transfection assay (Sichero et al., 2012). This assay
identiﬁed 28 transcription factors that stimulated and 36 that
repressed the LCR activities. While many of these effects may be
based on indirect mechanisms rather than binding of the factors to
the HPV LCRs, the authors identiﬁed binding sites for a subset of
potentially very important modulators of HPV transcription. Most
notably, FOXA1 with binding sites in the 5′ LCR of both viruses and
in the 3′ LCR of HPV18 massively stimulated transcriptional
activity, while MYC, binding to the 5′ LCR of HPV16 and the central
LCR of HPV18, represses transcription. Additional relevant factors
include GATA3 and TP53. Some of the observed effects may
account for differences in transcriptional activity that occur
between variants of HPV-16 and HPV-18, and may contribute to
the differential carcinogenicity of some of these variants (Sichero
et al., 2005). A similar high-throughput approach based on the
Panomics TranSignal array by Carson and Khan (2006) predated
the screens by Sichero and Coll and identiﬁed 36 factors that
bound a fragment representing most of the HPV16 LCR. Thirty-one
of these factors increased, and ﬁve decreased during cellular
differentiation. These factors included most of those speciﬁcally
studied in prior years, but added numerous factors previously not
known to bind the HPV16 LCR. These researchers speciﬁcally
studied seven factors by chromatin immune precipitation, leading
to conﬁrmation of NFI and C/EBPalpha binding sites, and adding as
newmodulators C-Myb, NFATx, Pax5, STAT5 and WT1. While these
two projects do not yet explain the intricacies of HPV16 and
HPV18 transcriptional modulation by these factors, they clearly
lead to the conclusion that many more complex mechanisms are
involved than those suggested by the previous research of the
1990s that targeted less than a dozen speciﬁc transcription factors.
The E7 promoter of HPV6 and 11 within the E6 gene
The E7 protein is expressed in most Alphapapillomaviruses from
a polycistronic mRNA that initiates at the E6 promoter by transla-
tion initiation within the E6 open reading frame (Roggenbuck
et al., 1991). An exception are HPV6 and 11, which contain a
separately regulated transcription start within the E6 gene, which
is linked to a ﬁfth E2 binding site, also located within E6 (Baker
and Calef, 1995).
The late promoter within the E7 gene
As the late genes L2 and L1 are physically separate and down-
stream of all early genes, one might expect that they are tran-
scribed from a promoter in the non-coding region that separates
early and late genes. Surprisingly, no such promoter seems to exist.
Instead, most L2 and L1 transcripts originate from a promoter in
the E7 gene that generates multiple start sites (P670 in HPV16,
P742 in HPV31), and the transcribed early region is spliced such
that the late mRNAs retain a short leader of the E1 gene and the E4
open reading frame.
Presently, neither the late promoter regulatory elements nor
the actual early-late switch (i.e. the differential activation of the
late promoter) are well understood, although mutational studies
of HPV16 and 31 point toward multiple cis-responsive elements
overlapping with the coding sequence of the E7 gene (Bodily and
Meyers, 2005; Bodily et al., 2011). HPV31 based experiments
H.-U. Bernard / Virology 445 (2013) 197–204202suggest that the promoter is affected by the enhancer in the
central LCR that activates E6 promoter (Wooldridge and Laimins,
2008) although possibly not linked to differentiation (Bodily and
Meyers, 2005). Data suggest a role of factors of the C/EBP family in
late promoter modulation (Kukimoto et al., 2006; Wooldridge and
Laimins, 2008; Gunasekharan et al., 2012). Another observation
points to competition between YY1 and hSkn-1a as a regulatory
tool of HPV16 P670 (Kukimoto and Kanda, 2001).Chromatin
The term “chromatin” refers to the interaction of DNA with
histones, leading to formation of nucleosomes, which consist of
147 bp DNA and pairs of the four different histones. Chromatin is
of great importance to gene regulation, as covalent modiﬁcations,
such as acetylation and methylation of histones are important
modulators of gene expression. This process is without doubt also
of great importance for papillomavirus biology, however yet little
studied. It also does not strictly fall under the topic of this chapter,
as nucleosomes do not recognize regulatory elements. It should be
stressed, however, that nucleosomes can form on preferential DNA
sequences, and this seems to be the case for HPV16 and 18, which
have each two speciﬁcally positioned nucleosomes placed over the
central LCR and E6 promoter sequences, respectively (Stünkel and
Bernard, 1999). The modulation of HPV promoters by chromatin
modiﬁcation has been shown in HPV31, where acetylation acti-
vates the early and late promoter (Wooldridge and Laimins, 2008).Nuclear matrix attachment
The concept of the nuclear matrix as a structure that anchors
DNA domains and likely brings them in contact with structurally
anchored regulatory proteins is very mature, but yet poorly
understood in detail. Here it should be mentioned that nuclear
matrix attachment regions (MARs) are much larger than transcrip-
tion factor binding sites. In HPVs, two MARs extend over much of
the 5′ LCR and the E6 gene, and these and other MARs may be
conserved among different Alphapapillomaviruses. MARs may
affect the activity of known enhancers and promoters (Tan et al.,
1998; Stünkel et al., 2000).Betapapillomaviruses
These viruses are associated with skin lesions, the best studied
types HPV5 and 8 notably with Epidermodysplasia verruciformis.
The LCR is fundamentally different from that of Alphapapilloma-
viruses. Conspicuous are its much smaller size (about 400 bp
rather than 850 bp) and a 60 bp segment upstream of the E6 start
site that has more than 80% As and Ts, and whose function is not
yet understood. The early promoter is – as in Alphapapillomaviruses
– upstream of the E6 gene, but the late promoter is not located in
E7, but within the LCR upstream of the early promoter. Modulation
by several trans-acting factors has been observed in HPV8, notably
induction by AP-1, NFI, RUNX1 and p53, and suppression by PBF,
IRF-5.2 and YY1 (reviewed in Steger and Pﬁster, 2007). Induction
and suppression of HPV8 by interferon regulatory factors 3 and
7 have been intensely studied, but the relevant cis-responsive
elements are not yet known (Oldak et al., 2011).
Bovine papillomavirus type 1
Studies of this virus have been at the forefront of under-
standing the functions of E2 protein as activator and repressor oftranscription and facilitator of viral partition during mitoses, as
described elsewhere in this issue. This virus has 17 E2 binding
sites, ten of these in the LCR. The latter are clustered remote from
viral promoters and their occupancy leads to an enhancer function.
Other E2 binding sites are spread throughout the early genes close
to various early promoter, and apparently affect function of the
transcription start sites (Li et al., 1989). The effects of cellular
transcription factors on BPV1 transcription is under researched,
but there is unequivocal evidence for involvement of such factors
(Haugen et al., 2009). As BPV1 also ampliﬁes in mouse ﬁbroblast
cultures, in contrast to all HPVs, the cellular factors induce
transcription without restrictions to epithelial cells.
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